Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Other Non Operating Income (2022 - 2025)

Praxis Precision Medicines has reported Other Non Operating Income over the past 4 years, most recently at $8.1 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 54.12% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $22.9 million, up 32.19%, while the annual FY2025 figure was $22.9 million, 32.19% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $8.1 million at Praxis Precision Medicines, up from $4.4 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $8.1 million in Q4 2025 and troughed at $132000.0 in Q1 2022.
  • A 4-year average of $2.8 million and a median of $1.6 million in 2023 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: surged 642.44% in 2024 and later decreased 10.15% in 2025.
  • Year by year, Other Non Operating Income stood at $280000.0 in 2022, then surged by 231.43% to $928000.0 in 2023, then skyrocketed by 468.64% to $5.3 million in 2024, then skyrocketed by 54.12% to $8.1 million in 2025.
  • Business Quant data shows Other Non Operating Income for PRAX at $8.1 million in Q4 2025, $4.4 million in Q3 2025, and $4.9 million in Q2 2025.